Adipotide (FTPP)Weight LossSafety Rating 3/10

Primary research areaTargeted fat loss (visceral and subcutaneous)

Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.

Research dose range250–500 mcg/day SC for 4 weeks maximum. Research compound — used with caution due to renal risk.
AdministrationVaries
Safety3/10 · Not FDA-approved
NCAA D1Banned

Price Comparison

Compare vendors · per 5mg

6 vendors competing

VendorPrice$ / mgUpdated
Biotech PeptidesBest $/mgCOA unknown$77.00$7.70May 14, 2026Buy →
Core PeptidesCOA ✓ · 3P$78.00$7.80Apr 16, 2026Buy →
LeoLab RxCOA ✓ · 3P$40.00$8.00Apr 6, 2026Buy →
Behemoth LabzCOA ✓ · 3P$102.62$10.26May 14, 2026Buy →
Swiss ChemsCOA ✓ · 3P$63.95$12.79Apr 17, 2026Buy →
$25 off $100+·auto

Overview

About Adipotide

Mechanism of action

Proapoptotic peptide that binds prohibitin on blood vessels feeding white adipose tissue; triggers apoptosis of adipose vasculature; causes selective destruction of fat tissue blood supply.

Safety profile

SIGNIFICANT: Renal toxicity (dehydration, kidney damage risk); requires high water intake; nausea, fatigue; not recommended for long cycles. Serious risk profile vs. other peptides. · Caused renal tubular damage in primate studies; proven organ toxicity in animal models

📈

Price tracking starts now.

Set an alert to get notified when this peptide drops.

Related pages

More on Adipotide

Failed to fetch